Table 4. Perceived barriers to advising adolescents aged 10–17 years for human papillomavirus (HPV) vaccination.
Extremely Likely or Somewhat Likely | Extremely Unlikely, Somewhat unlikely, or Neutral | |
Parental refusal | ||
Child too many vaccine | 198 (56.1) | 155 (43.9) |
Safety concern | 282 (78.6) | 77 (21.4) |
Not believe in vaccine | 201 (56.8) | 153 (43.2) |
Less attentive to vaccine once child is >5 years | 229 (62.6) | 137 (37.4) |
Parental reluctance to discuss sexuality/STD | 254 (70.4) | 107 (29.6) |
Parental perception of singling out their child as at risk for STD | 164 (44.9) | 201 (55.1) |
Parental concern of increasing risky behavior | 149 (41.0) | 214 (59.0) |
Frequent changes of recommendation for immunization | 155 (42.9) | 206 (57.1) |
Doctors’ reluctance to offer multiple vaccines | 107 (30.1) | 249 (69.9) |
Doctors’ reluctance to discuss sexuality/STD | 118 (32.3) | 247 (67.7) |
Difficult to get adolescents to show up for well visits/immunizations | 207 (58.0) | 150 (42.0) |
Doctors’ reluctance since regular pap smear is still needed after vaccine | 96 (26.4) | 268 (73.6) |
Doctors’ reluctance as vaccine’s protection is <100% | 102 (28.2) | 260 (71.8) |
Too low parental awareness, time-consuming | 187 (51.8) | 174 (48.2) |
Hard selling an expensive vaccine | 234 (65.0) | 126 (35.0) |
Vaccination not related to the reasons of consultation | 201 (55.7) | 160 (44.3) |
Not the doctors’ responsibility | 65 (18.5) | 286 (81.5) |
Difficulty to initiate the conversation | 125 (34.4) | 238 (65.6) |
Most adolescent patients not at risk for HPV infection | 86 (24.2) | 269 (75.8) |
Most adolescent patients not at risk for cervical cancer | 85 (23.5) | 277 (76.5) |
STD: Sexually Transmitted Disease.